On Q Group Limited Stock Australian S.E.
Equities
AU000000ONQ3
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- AUD | - |
|
06-06 | BPH Global to Source Bird's Nest Products from China's Sinopharm; Shares Plummet 40% | MT |
05-14 | BPH Global Enters Term Sheet with Nutura Organic to Undertake Pilot Study in China | MT |
Sales 2022 | 14.35M 9.49M 13.05M | Sales 2023 | 339 224.06 308.18 | Capitalization | 3.85M 2.55M 3.5M |
---|---|---|---|---|---|
Net income 2022 | -3M -1.98M -2.73M | Net income 2023 | -4M -2.64M -3.64M | EV / Sales 2022 | 1.07 x |
Net Debt 2022 | 627K 414K 570K | Net cash position 2023 | 511K 338K 465K | EV / Sales 2023 | 9,862 x |
P/E ratio 2022 |
-3.97
x | P/E ratio 2023 |
-0.72
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 35.24% |
Managers | Title | Age | Since |
---|---|---|---|
Matthew Leonard
CEO | Chief Executive Officer | 53 | 23-03-29 |
Justyn Stedwell
SEC | Corporate Secretary | - | 04-10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 21-07-20 | |
Paul Stephenson
CHM | Chairman | 63 | 20-03-30 |
Yan Hua Huang
BRD | Director/Board Member | - | 19-05-26 |
1st Jan change | Capi. | |
---|---|---|
+49.41% | 57.87B | |
+41.65% | 40.25B | |
-6.72% | 39.94B | |
-5.96% | 28.54B | |
+12.99% | 26.4B | |
-19.82% | 19.33B | |
+32.35% | 12.4B | |
-0.08% | 12.23B | |
+25.18% | 12.2B |